83 related articles for article (PubMed ID: 20869182)
41. Establishing an anal dysplasia clinic for HIV-infected men: initial experience.
Siekas LL; Aboulafia DM
AIDS Read; 2009 May; 19(5):178-86. PubMed ID: 19554736
[TBL] [Abstract][Full Text] [Related]
42. The fear factor: drivers and barriers to follow-up screening for human papillomavirus-related anal cancer in men who have sex with men.
Truesdale MD; Goldstone SE
Int J STD AIDS; 2010 Jul; 21(7):482-8. PubMed ID: 20852198
[TBL] [Abstract][Full Text] [Related]
43. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
[TBL] [Abstract][Full Text] [Related]
44. Should the treatment of anal carcinoma be adapted in the elderly? A retrospective analysis of toxicities in a French center.
Bari BD; Chekrine T; Shakir IS; Ardiet JM; Gerard JP; Chapet O; Mornex F
J Clin Gastroenterol; 2011 Sep; 45(8):738-9. PubMed ID: 21552136
[No Abstract] [Full Text] [Related]
45. The cost of anal cancer in England: retrospective hospital data analysis and Markov model.
Keeping ST; Tempest MJ; Stephens SJ; Carroll SM; Nugent KP; O'Dwyer ST
BMC Public Health; 2014 Oct; 14():1123. PubMed ID: 25361522
[TBL] [Abstract][Full Text] [Related]
46. Initial management through the anal cancer multidisciplinary team meeting.
Renehan AG; O'Dwyer ST
Colorectal Dis; 2011 Feb; 13 Suppl 1():21-8. PubMed ID: 21251169
[No Abstract] [Full Text] [Related]
47. JAMA patient page. Anal cancer.
Zeller JL; Lynm C; Glass RM
JAMA; 2008 Apr; 299(16):1980. PubMed ID: 18430917
[No Abstract] [Full Text] [Related]
48. Health agencies update: anal cancer screening.
Stephenson J
JAMA; 2000 Jun; 283(23):3060. PubMed ID: 10865288
[No Abstract] [Full Text] [Related]
49. Epidemiological and economic burden of potentially HPV-related cancers in France.
Abramowitz L; Lacau Saint Guily J; Moyal-Barracco M; Bergeron C; Borne H; Dahlab A; Bresse X; Uhart M; Cancalon C; Catella L; Bénard S
PLoS One; 2018; 13(9):e0202564. PubMed ID: 30235216
[TBL] [Abstract][Full Text] [Related]
50. Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States.
Deshmukh AA; Zhao H; Franzini L; Lairson DR; Chiao EY; Das P; Swartz MD; Giordano SH; Cantor SB
Am J Clin Oncol; 2018 Feb; 41(2):121-127. PubMed ID: 26523440
[TBL] [Abstract][Full Text] [Related]
51. Awareness and acceptance of human papillomavirus (HPV) vaccination among males attending a major sexual health clinic in Wuxi, China: A cross-sectional study.
Zou H; Meng X; Jia T; Zhu C; Chen X; Li X; Xu J; Ma W; Zhang X
Hum Vaccin Immunother; 2016 Jun; 12(6):1551-9. PubMed ID: 26467510
[TBL] [Abstract][Full Text] [Related]
52. A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France.
Bresse X; Adam M; Largeron N; Roze S; Marty R
Hum Vaccin Immunother; 2013 Apr; 9(4):823-33. PubMed ID: 23563511
[TBL] [Abstract][Full Text] [Related]
53. Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark.
Olsen J; Jørgensen TR; Kofoed K; Larsen HK
BMC Public Health; 2012 Dec; 12():1082. PubMed ID: 23244352
[TBL] [Abstract][Full Text] [Related]
54. Economic burden of human papillomavirus-related diseases in Italy.
Baio G; Capone A; Marcellusi A; Mennini FS; Favato G
PLoS One; 2012; 7(11):e49699. PubMed ID: 23185412
[TBL] [Abstract][Full Text] [Related]
55. Economic burden of anal cancer management in France.
Abramowitz L; Rémy V; Vainchtock A
Rev Epidemiol Sante Publique; 2010 Oct; 58(5):331-8. PubMed ID: 20869182
[TBL] [Abstract][Full Text] [Related]
56. Annual cost of hospitalization, inpatient rehabilitation and sick leave of anal cancer in Germany.
Heitland W; Schädlich PK; Chen X; Rémy V; Moro L
J Med Econ; 2013; 16(3):364-71. PubMed ID: 23253056
[TBL] [Abstract][Full Text] [Related]
57. [Screening and therapy of anal intraepithelial neoplasia (AIN) and anal carcinoma in patients with HIV-infection].
Kreuter A; Reimann G; Esser S; Rasokat H; Hartmann M; Swoboda J; Conant MA; Tschachler E; Arasteh K; Altmeyer P; Brockmeyer NH
Dtsch Med Wochenschr; 2003 Sep; 128(38):1957-62. PubMed ID: 14502448
[TBL] [Abstract][Full Text] [Related]
58. Economic burden of HPV-related cancers in France.
Borget I; Abramowitz L; Mathevet P
Vaccine; 2011 Jul; 29(32):5245-9. PubMed ID: 21616117
[TBL] [Abstract][Full Text] [Related]
59. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
Chin-Hong PV; Vittinghoff E; Cranston RD; Browne L; Buchbinder S; Colfax G; Da Costa M; Darragh T; Benet DJ; Judson F; Koblin B; Mayer KH; Palefsky JM
J Natl Cancer Inst; 2005 Jun; 97(12):896-905. PubMed ID: 15956651
[TBL] [Abstract][Full Text] [Related]
60. On the etiology of anal squamous carcinoma.
Frisch M
Dan Med Bull; 2002 Aug; 49(3):194-209. PubMed ID: 12238281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
